GLP-1/GIP/glucagon/IGF-1 receptors (quadruple)

Class

Quadruple GLP-1/GIP/glucagon/IGF-1 receptor agonist

This mechanism combines agonism of four distinct receptors: three related receptors that regulate glucose and energy balance (GLP-1, GIP, and glucagon receptors, all class B G-protein-coupled receptors expressed in the pancreas, gut, brain, and liver) plus the IGF-1 receptor, a growth-factor receptor with a very different biology. GLP-1 and GIP receptor activation enhances glucose-dependent insulin release and reduces appetite, while glucagon receptor activation raises hepatic glucose output but also increases energy expenditure. Combining these three creates synergistic effects on weight and blood sugar beyond what any single receptor achieves. The addition of IGF-1 receptor agonism is unusual: this receptor normally transmits growth and tissue-building signals rather than metabolic ones. Its inclusion reflects an effort to counteract a known limitation of incretin-based weight-loss therapies, namely the loss of lean muscle mass that accompanies fat loss, by simultaneously promoting anabolic, muscle-preserving signaling. This mechanism is broadly relevant to obesity, type 2 diabetes, and metabolic liver disease, where multi-hormone approaches are being explored to improve efficacy and body-composition outcomes beyond single-receptor agents.